Micrazym 25000 units gastro-resistant capsules, hard
Authorisation PA22871/030/002 · Azure Pharmaceuticals Ltd.
- Licence holder
- Azure Pharmaceuticals Ltd. (all products →)
- Active substance
- Pancreatin
- Dosage form
- Gastro-resistant capsule, hard
- Route of administration
- Oral use
- ATC code
- A09AA02
- First authorised
- 10/01/2025
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Pancreatin: supply and approvals
11 authorised products on the HPRA list contain Pancreatin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 1 year (since 10 January 2025). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.
Other medicines with Pancreatin in Ireland
10 other products on the HPRA list contain Pancreatin, from 4 licence holders; 3 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Creon 10000 Gastro-resistant Capsules | Viatris Healthcare Limited | National authorisation (PA) | Marketed |
| Creon 25000 Gastro-resistant Capsules | Viatris Healthcare Limited | National authorisation (PA) | Marketed |
| Creon for Children 5000 Gastro-resistant Granules | Viatris Healthcare Limited | National authorisation (PA) | Marketed |
| Creon 10000 Gastro-Resistant Capsules | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Creon 10000 Gastro-resistant Capsules | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
| Creon 20000 Gastro-resistant Capsules, hard | Viatris Healthcare Limited | National authorisation (PA) | Not marketed |
| Creon 25000 Gastro-resistant Capsules | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
| Creon 25000 Gastro-resistant capsules | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Creon 35000 Gastro-resistant Capsules, hard | Viatris Healthcare Limited | National authorisation (PA) | Not marketed |
| Micrazym 10000 units gastro-resistant capsules, hard | Azure Pharmaceuticals Ltd. | National authorisation (PA) | Not marketed |
The licence holder
Azure Pharmaceuticals Ltd. holds 45 products on the HPRA list, with 23 different active substances; 21 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.